Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses

Summary

Stanford University researchers have developed a nasal spray vaccine that could provide universal protection against all coughs, colds, flus, and bacterial lung infections, potentially even easing allergies. The vaccine represents a radical departure from traditional approaches by targeting the immune system's first line of defense in the nose and throat rather than specific pathogens. While promising animal trials have been completed, human clinical trials are still needed to confirm safety and efficacy.